A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan

Clinical Immunology

Volumn 110, Issue 2, 2004, Pages 154-158

  Shinomiya, Noriaki ^a   Nomura, Yoshiko ^b   Segawa, Masaya ^b  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b Segawa Neurol Clinic for Children   (Japan)

Author keywords

Anti acetylcholine receptor antibody; HLA DR DQ haplotype; Latent general type; Myasthenia gravis with childhood onset; Ocular symptoms

Indexed keywords

HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROMYOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HLA TYPING; HUMAN; INFANT; JAPAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MUSCLE; MYASTHENIA GRAVIS; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DNA; ELECTROMYOGRAPHY; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; JAPAN; MALE; MYASTHENIA GRAVIS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; RECEPTORS, CHOLINERGIC; VARIATION (GENETICS);

EID: 1542360725     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.10.004     Document Type: Article

References (20)

1. Vincent A., Drachman D.B. Myasthenia gravis. Pourmand R., Harati Y. Advances in Neurology. vol. 88:2001;159-188 Lippincott Williams & Wilkins, Philadelphia, PA.
2. Shinomiya N., Shinomiya M., Nomura Y., Segawa M. Analysis of HLA-DPB1 allele associated with childhood-onset myasthenia gravis. J. Med. Soc. Toho. 43:1997;473-483.
3. Jaretzki A. III, Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis; recommendation for clinical research standards. Neurology. 55:2000;16-23.
4. Hjelmstrom P., Sanjeevi C.B. Molecular mechanisms of MHC association with myasthenia gravis. Christadoss P. Myastenia Gravis: Disease Mechanisms and Immunointervention. 2000;94-104 Narosa Publishing House, New Delhi.
5. Degli-Esposti M.A., Andreas A., Christiansen F.T., Schalke B., Albert E., Dawkins R.L. An approach to localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 35:1992;355-364.
6. Matsuki K., Juji T., Tokunaga K., Takamizawa M., Maeda H., Soda M., Nomura Y., Segawa M. HLA antigens in Japanese patients with myasthenia gravis. J. Clin. Invest. 86:1990;392-399.
7. Hawkins B.R., Yu Y.L., Wong V., Woo E., Dawkins R.L. Possible evidence for a variant of myasthenia gravis based on HLA and acetylcholine receptor antibody in Chinese patients. Q. J. Med. 70:1989;235-241.
8. Segawa M. Myasthenia gravis - Latent general type. Naika. 31:1973;1222-1226.
9. Igata A. Diagnostic criteria for myasthenia gravis. Igata A. Proceeding of Neuroimmunological Disorders. 1986;1-4 Ministry of Health and Welfare of Japan, Tokyo.
10. Zwallow P., Ansari A.A., Marsh D.G. Association of class II DNA restriction fragments with responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a V in ragweed-allergic patients. J. Allergy Clin. Immunol. 83:1989;45-54.
11. Uono K., Yagi K., Beppu H., Nagano H. The clinical significance of anti-nicotinic acetylcholine receptor antibodies in myasthenia gravis. Annual Report of National Research Committee against Myasthenia Gravis. 1979;80-85 Ministry of Health and Welfare of Japan, Tokyo.
12. Desmedt J.E. Presynaptic mechanisms in myasthenia gravis. Ann. N. Y. Acad. Sci. 135:1966;209-246.
13. Keesey C.J. Electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve. 12:1989;613-623.
14. Chiu H.-C., Vincent A., Newsom-Davis J., Hsieh K.-H., Hung T.-P. Myasthenia gravis: population difference in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology. 37:1987;1854-1857.
15. Wong V., Hawkins B.R., Yu Y.L. 1992 Myasthenia gravis in Hong Kong Chinese, 2. Paediatric disease. Acta Neurol. Scand. 86:1992;68-72.
16. Personal communication.
17. Shinomiya N. Analysis of the immunological pathogenesis of the seronegative autoimmune disease. Jpn. J. Clin. Immunol. 25:2002;302-309.
18. Tokunaga K., Kay P.H., Christiansen T.F., Saueracker T., Dawkins L.R. Comparative mapping of the human major histocompatibility complex in different racial group by pulsed field gel electrophoresis. Hum. Immunol. 26:1989;99-106.
19. Oen K., Schroeder M., Jacobson K., Anderson S., Wood S., Cheung M., Dooley T. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: onset subtypes and HLA association. J. Rheumatol. 25:1998;783-790.
20. Sugihara S., Sakamaki T., Konda S., Murata A., Watuki K., Kobayashi Y., Minamitani K., Miyamoto S., Sasaki N., Niimi H. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes. 46:1997;1893-1897.